VBL Therapeutics
Manufacturing · Israel · 1-10 Employees
View Company Info for Free
Overview
Headquarters
8 Hasatat St, Modi'in, Central District,...Phone Number
+972 89935000Website
www.vblrx.comRevenue
<$5 MillionStock Symbol
VBLTIndustry
About VBL Therapeutics
Vascular Biogenics Ltd., operating as VBL Therapeutics, is a clinical stage biopharmaceutical company focused on the discovery, development and commercialization of first-in-class treatments for cancer. VBL's lead oncology product candidate, ofranergene obadenovec (VB-111), is a targeted anti-cancer gene-therapy agent that is being developed to treat a wide range of solid tumors. VBL Therapeutics is headquartered in Israel.Explore more
VBL Therapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
VBL Therapeutics Tech Stack
A closer look at the technologies used by VBL Therapeutics
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding VBL Therapeutics
Sign Up For FreeTo access detailed company insights
Vascular Biogenics Ltd., operating as VBL Therapeutics, is a clinical stage biopharmaceutical company focused on the discovery, development and commercialization of first-in-class treatments for cancer. VBL's lead oncology product candidate, ofranergene obadenovec (VB-111), is a targeted anti-cancer gene-therapy agent that is being developed to tre... Read More
